← Back to Search

Behavioral Intervention

Behavioral Task Performance for Psychiatric Symptoms (CABxtime Trial)

N/A
Waitlist Available
Led By John P O'Doherty, D.Phil
Research Sponsored by California Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age range of 18 to 65
Age range of 18 to 65
Must not have
Prior history and or current diagnosis of neurological disease
Prior history and or current diagnosis of neurological disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to understand how different mental health conditions are linked to how people perform tasks. The researchers will study this relationship over a year by looking at how well participants complete tasks and their psychiatric symptoms.

Who is the study for?
This trial is for adults aged 18-65. It includes healthy individuals without psychiatric diagnoses and patients with depression, anxiety disorders, or OCD. Participants must be able to understand and perform tasks and give informed consent. Exclusions are neurological diseases, psychotic disorders, or active substance use disorder.
What is being tested?
The study examines how well computational analysis of task performance can predict psychiatric symptoms over a year. It involves both healthy people and those with certain mental health conditions from online platforms and UCLA clinics.
What are the potential side effects?
Since the intervention involves behavioral task performance rather than medication, traditional side effects are not applicable. However, participants may experience stress or discomfort while completing the tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with depression, anxiety, or OCD.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history or current diagnosis of a neurological disease.
Select...
I have a history or current diagnosis of a neurological disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in DASS anxiety scale scores
Changes in DASS depression scale scores
Changes in OCI-R scores
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Behavioral task batteryExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

California Institute of TechnologyLead Sponsor
16 Previous Clinical Trials
3,249 Total Patients Enrolled
1 Trials studying Depression
165 Patients Enrolled for Depression
John P O'Doherty, D.PhilPrincipal InvestigatorCalifornia Institute of Technology
~733 spots leftby Dec 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top